COVID-19 News

September 25, 2020September 25, 2020

Cure Sanfilippo Foundation Aims to Educate on Remote Learning for Special Needs Children

A new initiative led by the Cure Sanfilippo Foundation is seeking to provide more insight on the impact of remote learning on children with Sanfilippo syndrome and other developmental disorders. The ... Read more

September 24, 2020September 24, 2020

OMRF Opening Study Into Onset and Progression of Sarcoidosis

COVID-19 News, Sarcoidosis News

People with sarcoidosis are being asked to donate blood samples and information related to their disease to help the Oklahoma Medical Research Foundation (OMRF) further its work into how sarcoidosis develops ... Read more

September 23, 2020September 24, 2020

New Virtual Tool May Allow Fast, Accurate PH Diagnosis During COVID-19

COVID-19 News, Pulmonary Hypertension News

A new virtual tool, called VEST, is aiding clinicians in remotely diagnosing people with Group 1 pulmonary hypertension (PH) per the World Health Organization (WHO) classification, a new study reports. ... Read more

September 23, 2020

COVID-19: Your Weekly Roundup of Key Developments

COVID-19 News

Sinovac launches Phase 3 trial for CoronaVac in Turkey Sinovac has begun a Phase 3 trial for its COVID-19 vaccine candidate, called CoronaVac, in Turkey. The first part of the ... Read more

September 22, 2020September 22, 2020

Cognitive Changes Are Most Challenging Symptom for Parkinson’s Care Partners, Research Reveals

COVID-19 News, Parkinson's News Today

Cognitive changes in people with Parkinson’s disease pose a substantial challenge for their care partners, new research suggests. The findings were presented at the 2020 Congress of Parkinson’s Disease and ... Read more

September 22, 2020September 22, 2020

Muscular Dystrophy and Other Clinical Trials Adapting to Life With COVID-19

COVID-19 News, Muscular Dystrophy News

In a Facebook Live event hosted by the Muscular Dystrophy Association (MDA), experts discussed the effect that the COVID-19 pandemic has had on research efforts in muscular dystrophy, as well ... Read more

September 22, 2020September 22, 2020

Gilenya Remains Favorite S1P Receptor Modulator in US, But Zeposia May Catch Up, Survey Finds

COVID-19 News, Multiple Sclerosis News Today

Among oral sphingosine-1-phosphate (S1P) receptor modulators for multiple sclerosis (MS), Novartis’s Gilenya (fingolimod) remains physicians’ favorite in the U.S., but prescriptions of recently-launched Bristol Myers Squibb’s Zeposia (ozanimod) are beginning to ... Read more

September 21, 2020September 21, 2020

Large Survey to Identify Unmet Needs of Underserved Parkinson’s Populations in US

COVID-19 News, Parkinson's News Today

The Parkinson’s Foundation is launching a large paper-based survey to identify gaps in existing research in traditionally underserved people with Parkinson’s disease by gathering patient-reported information about treatment and care, ... Read more

September 18, 2020September 18, 2020

E-cigarette Use Linked to Bronchiectasis in 3 Cases, Report Suggests

Bronchiectasis News Today, COVID-19 News

Use of electronic cigarettes, or e-cigarettes, is strongly suspected to have led to bronchiectasis in three young patients, according to a recent report. The use of e-cigarettes has not yet ... Read more

September 18, 2020September 18, 2020

National MS Society Launches Survey to Assess Economic Impact of MS

COVID-19 News, Multiple Sclerosis News Today

The National Multiple Sclerosis Society, together with the Lewin Group, has launched a survey to assess the economic impact multiple sclerosis (MS) has on patients and their families. In the ... Read more

September 17, 2020September 17, 2020

FDA Grants Rare Pediatric Disease Status to AML Therapy OXi-4503

Acute Myeloid Leukemia News, COVID-19 News

The U.S. Food and Drug Administration (FDA) has granted its Rare Pediatric Disease designation to Mateon Therapeutics’ OXi-4503 (combretastatin A1-diphosphate, CA1P) for the treatment of children and teens with acute ... Read more

September 17, 2020September 17, 2020

Patients With Impaired Lung Function May Have Higher Risk of Severe COVID-19

COVID-19 News, Sarcoidosis News

People with sarcoidosis who have impaired lung function seem to be at greater risk for severe COVID-19 disease, a new study suggests. The study, “Moderate or Severe Impairment in Pulmonary Function ... Read more

September 17, 2020September 17, 2020

Gene Therapy VY-AADC Improves Motor Function in Parkinson’s Patients, Studies Show

COVID-19 News, Parkinson's News Today

One-time treatment with investigational gene therapy VY-AADC (NBIb-1817) showed sustained improvement in motor function in patients with Parkinson’s, results from the Phase 1 PD-1102 clinical trial show. These results were ... Read more

September 17, 2020September 17, 2020

GreenLight Wins $3.3M Grant to Pursue mRNA-based Gene Therapies

COVID-19 News, Sickle Cell Disease News

The Bill & Melinda Gates Foundation has awarded a $3.3 million grant to GreenLight Biosciences to develop gene therapies revolving around messenger RNA (mRNA) — the intermediate molecule between DNA ... Read more

September 16, 2020September 17, 2020

Theme for World Alzheimer’s Month Is ‘Let’s Talk About Dementia’

Alzheimer's News Today, COVID-19 News

Events are underway to mark World Alzheimer’s Month, observed every September to raise global awareness about the disease and challenge the stigma regarding dementia. September 21 has been designated World Alzheimer’s ... Read more